Search the Newsreel

Dr. Reddy’s Laboratories (RDY) CEO API & Services Deepak Sapra resigns effective November 12, 2026

Dr. Reddy’s Laboratories announced that Deepak Sapra, CEO of API & Services and a Senior Management Personnel, has resigned to pursue outside opportunities. His resignation is effective November 12, 2026, and he will remain with the company until then to ensure a smooth transition …

Silicon Labs: Medical Revenue Surges 78% To Record As IoT Design Wins Accelerate

Silicon Labs reported a record 78% year-over-year increase in Medical revenue for Q2, driven by accelerating IoT design wins and stronger demand across its portfolio. Total Q2 revenue rose 18% to $228 million, with significant growth in Industrial & Commercial and Home & Life …

Taboola.com Ltd (TBLA) News, Articles, Events & Latest Updates

Several law firms, including Glancy Prongay Wolke & Rotter LLP, Law Offices of Howard G. Smith, and The Law Offices of Frank R. Cruz, are investigating Taboola.com Ltd. (TBLA) for potential violations of federal securities laws, urging shareholders who lost money to contact them. …

Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research

Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More

This article details Wall Street analyst upgrades, downgrades, and initiations for various companies on Thursday, August 13, 2026, following the release of inline CPI data. Key movements include Five Below being upgraded to Buy at Jefferies and StubHub being cut to Underperform at Bank …

Die Abbott-Laboratories-Aktie legt nach starken Quartalszahlen und solider Guidance zu

JHS Svendgaard Q1 Results: Net profit rises 156% YoY to ₹24 lakh

Silicon Labs (SLAB) Stock Looks Above Fair Value After A 67% Run

Silicon Laboratories (SLAB) stock has seen a 67.3% return over the last year, but current valuations suggest it may be above fair value. Trading at a P/S ratio of 8.8x, higher than the industry average, the stock screens as overvalued. While recent revenue and …

Wasatch Advisors LP Increases Position in Mesa Laboratories, Inc. $MLAB

Wasatch Advisors LP significantly increased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 125.8% in the second quarter, now owning 115,668 shares valued at $11.5 million. This comes as other institutional investors also adjusted their positions in the medical instruments supplier. Despite an overall …

What Dolby Laboratories (DLB)'s Dolby Vision 2 TV Rollout and VVC IP Push Mean For Shareholders

V. M. Manning & CO. Inc. Acquires New Position in Abbott Laboratories $ABT

V. M. Manning & CO. Inc. has acquired a new stake in Abbott Laboratories, purchasing 19,849 shares valued at approximately $1.8 million, making it their 11th largest holding. This move comes as Abbott Laboratories exceeded its quarterly earnings expectations and maintains a positive outlook …

McCollum Christoferson Group LLC Sells 62,644 Shares of Abbott Laboratories $ABT

United Laboratories Schedules Board Meeting to Approve 2026 Interim Results

Core Laboratories Inc. (CLB) stock price, news, quote and history

Renaissance Technologies LLC Buys 11,800 Shares of Nabors Industries Ltd. $NBR

Renaissance Technologies LLC significantly increased its stake in Nabors Industries Ltd. by 236% during the first quarter, acquiring an additional 11,800 shares to bring its total holdings to 16,800 shares valued at approximately $1.45 million. Institutional investors collectively own about 81.92% of Nabors Industries, …

Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Rating of "Reduce" from Brokerages

IDEXX (IDXX) Stock Looks Fair On Cash Flow But Rich On Earnings

Abbott Laboratories $ABT Shares Acquired by DAVENPORT & Co LLC

IPCALAB: Net profit surged 80% year-over-year on strong revenue and margin expansion across key segments

Abbott Laboratories Aktie | US0028241000 | ETR:ABL | News & Aktienkurs | FRA:ABL

Brooks Laboratories sets remote e-voting window for September 3 AGM

Dr. Reddy's Laboratories advances Thursday, outperforms competitors

Shares of Dr. Reddy's Laboratories Ltd. (500124) increased by 0.59% to 1,206.00 Indian rupees on Thursday. This occurred during a positive trading session for the stock market, with the BSE SENSEX Index (1) rising by 0.15%. The company's shares closed 14.73% below their 52-week …

Ipca Laboratories shares gain over 2% to Rs 1,802.60

Rep. Mike Kelly Unloads Abbott Laboratories (NYSE:ABT) Shares

Representative Mike Kelly sold shares of Abbott Laboratories (NYSE:ABT) valued between $1,001 and $15,000 on July 17th, as well as shares of PepsiCo and Walt Disney on the same day. This sale occurred despite Abbott Laboratories reporting a quarterly earnings beat and reaffirming its …

Bio Rad Laboratories (BIO) Issues Flat Revenue Guidance, Is It Too Far Above Fair Value?

Bio-Rad Laboratories (BIO) has seen a sharp increase in its stock price over the last 90 days, despite recent flat revenue guidance and a significant long-term decline in shareholder return. The company is currently trading above its fair value estimate of $293, driven by …

Is Peabody Energy’s Centurion Lawsuit Quietly Reframing the BTU Management Credibility Narrative?

Cabot Corporation Prices $350 Million 4.950% Senior Notes Due 2029

Cabot Corporation announced the pricing of a public offering of $350 million in 4.950% senior unsecured notes due 2029. The sale is expected to close on August 21, 2026, with proceeds intended to repay existing senior unsecured notes due September 2026, and for working …

Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?

IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proBNP Test, the first dual-species, in-clinic NT-proBNP cardiac test, expanding its connected …

Silicon Labs (SLAB) Stock Carries A Premium As Losses Persist

Silicon Laboratories (SLAB) stock remains highly valued despite continuing to report net losses and negative basic earnings per share. While Q2 2026 results showed narrowed losses and increased revenue driven by IoT segments, concerns persist regarding the company's profitability and execution risk, especially with …

Mike Kelly makes multiple trades including Abbott Laboratories and Disney stocks

Congressman Mike Kelly recently executed several trades through the Victoria Kelly Trust ICA, including selling stocks from Abbott Laboratories and The Walt Disney Company, each valued between $1,001 and $15,000. He also sold Pepsico, Inc. stocks worth $15,001 to $50,000. Additionally, Kelly purchased government …

Cabot Sets 4.950% Interest on $350M Senior Notes Due 2029

Cabot Corporation has priced a public offering of $350 million in 4.950% senior unsecured notes due 2029, with interest to be paid semiannually. The offering is expected to close on August 21, 2026, and the net proceeds will primarily be used to repay existing …

Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Abbott Laboratories (NYSE:ABT) and Google Health announced a multi year partnership to integrate Abbott's Lingo biowearable glucose data with Google's AI driven consumer health …

ABBOTT LABORATORIES AKTIE: AI-Analysen, Prognose & Kursziel

Dolby Laboratories (DLB) VP Nicholson sells 1,348 Class A shares at $62.04

Ryan Nicholson, VP, CAO and Corporate Controller of Dolby Laboratories (DLB), sold 1,348 shares of Class A common stock at $62.04 per share on August 10, 2026. Following this transaction, Nicholson directly holds 35,636 shares, which includes 19,303 shares of restricted stock units that …